A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC)

Clinical trial NCT01551056 · COMPLETED

Trial details

NCT number: NCT01551056
Sponsor: Aciex Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Conjunctivitis

Start date: 2012-03-01
Primary completion: 2012-06-01
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.